{"address1": "5858 Horton Street", "address2": "Suite 370", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 318 9098", "website": "https://www.estrellabio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Cheng  Liu Ph.D.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jiandong  Xu", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9273, "open": 0.9, "dayLow": 0.7301, "dayHigh": 1.02, "regularMarketPreviousClose": 0.9273, "regularMarketOpen": 0.9, "regularMarketDayLow": 0.7301, "regularMarketDayHigh": 1.02, "payoutRatio": 0.0, "beta": 0.405, "volume": 222694, "regularMarketVolume": 222694, "averageVolume": 64720, "averageVolume10days": 41600, "averageDailyVolume10Day": 41600, "bid": 0.0, "ask": 0.9303, "bidSize": 0, "askSize": 1, "marketCap": 27485856, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 3.23, "fiftyDayAverage": 1.08012, "twoHundredDayAverage": 1.118825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 25692344, "forwardPE": -1.0133333, "profitMargins": 0.0, "floatShares": 9922029, "sharesOutstanding": 36165600, "sharesShort": 22554, "sharesShortPriorMonth": 4872, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.00059999997, "heldPercentInsiders": 0.72086, "heldPercentInstitutions": 0.00808, "shortRatio": 0.14, "shortPercentOfFloat": 0.0022, "impliedSharesOutstanding": 36165600, "bookValue": 0.004, "priceToBook": 189.99998, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -8854054, "trailingEps": -0.24, "52WeekChange": -0.3770492, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.76, "targetHighPrice": 16.0, "targetLowPrice": 16.0, "targetMeanPrice": 16.0, "targetMedianPrice": 16.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1797503, "totalCashPerShare": 0.05, "totalDebt": 4000, "quickRatio": 0.306, "currentRatio": 0.547, "debtToEquity": 0.536, "operatingCashflow": -6227052, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ESLA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -18.041626, "regularMarketPrice": 0.76, "marketState": "PRE", "shortName": "Estrella Immunopharma, Inc.", "longName": "Estrella Immunopharma, Inc.", "fiftyDayAverageChange": -0.32011998, "fiftyDayAverageChangePercent": -0.29637447, "twoHundredDayAverageChange": -0.35882497, "twoHundredDayAverageChangePercent": -0.3207159, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631626200000, "regularMarketChange": -0.16729999, "regularMarketDayRange": "0.7301 - 1.02", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 64720, "fiftyTwoWeekLowChange": 0.13, "fiftyTwoWeekLowChangePercent": 0.2063492, "fiftyTwoWeekRange": "0.63 - 3.23", "fiftyTwoWeekHighChange": -2.47, "fiftyTwoWeekHighChangePercent": -0.7647059, "fiftyTwoWeekChangePercent": -37.70492, "epsTrailingTwelveMonths": -0.24, "epsCurrentYear": -0.46, "priceEpsCurrentYear": -1.6521739, "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_1802952199", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Estrella Immunopharma", "trailingPegRatio": null}